Combination of two drugs could be effective strategy to target T-cell lymphocytic leukemia - Hallo friendsLET'S HEALTHY LIFE, In the article you read this time with the title Combination of two drugs could be effective strategy to target T-cell lymphocytic leukemia, We have prepared this article for you to read and retrieve information therein. Hopefully the contents of postings Article cough, Article diabetes, Article diseases, Article in general, Article Phytotherapy, Article skin diseases, We write this you can understand. Alright, good read.

Title : Combination of two drugs could be effective strategy to target T-cell lymphocytic leukemia
link : Combination of two drugs could be effective strategy to target T-cell lymphocytic leukemia

Combination of two drugs could be effective strategy to target T-cell lymphocytic leukemia

Researchers have determined that two Phase 1 drugs (CX-4945 and JQ1) can work together to efficiently kill T-cell acute lymphoblastic leukemia cells while having minimal impact on normal blood cells.

 JQ1     CX-4945

Although both drugs were previously tested as single agents in clinical trials to treat cancers, the success of the combined actions on cancer cells was previously unknown until now. The findings appear in the journal Haematologica.

Acute lymphoblastic leukemia, also known as acute lymphocytic leukemia or acute lymphoid leukemia, is a form of cancer of the white blood cells, characterized by the overproduction and accumulation of cancerous, immature white blood cells, known as lymphoblasts. Despite treatment improvement, T-cell leukemia remains fatal in 20 percent of pediatric and 50 percent of adult patients. Both CX-4945 and JQ1 are in clinical trials now as single agents to treat solid and hematological cancers.

"Previous studies provided us a rationale to test the combination of CX-4945 and JQ1 on refractory/relapsed T-cell leukemia," said corresponding author Hui Feng, MD, PhD, assistant professor of pharmacology & experimental therapeutics at Boston University School of Medicine (BUSM). "Our findings suggest that the combination treatment of CX-4945 and JQ1 could be an effective strategy to target refractory/relapsed T-cell leukemia," she added.

According to the researchers the efficacy of using a combination of JQ1 and CX-4945 in treating other cancers should also be investigated.

Ref : http://ift.tt/2tY2tCW

Combination of two drugs could be effective strategy to target T-cell lymphocytic leukemia

Medicinal Chemistry

Thus Article Combination of two drugs could be effective strategy to target T-cell lymphocytic leukemia

That's an article Combination of two drugs could be effective strategy to target T-cell lymphocytic leukemia This time, hopefully can give benefits to all of you. well, see you in posting other articles.

You are now reading the article Combination of two drugs could be effective strategy to target T-cell lymphocytic leukemia with the link address https://letslifes.blogspot.com/2017/07/combination-of-two-drugs-could-be.html

Tweet

Subscribe to receive free email updates: